Moseley Investment Management Inc Crispr Therapeutics Ag Transaction History

Moseley Investment Management Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 25, 2022	SELL	$70.09 - $111.29 $186,789 - $296,587	-2,665 Closed	0 $0
Q3 2021 Oct 27, 2021	BUY	$110.2 - $156.64 $7,603 - $10,808	69 Added 2.66%	2,665 $297,000
Q2 2021 Aug 11, 2021	BUY	$100.84 - $161.89 $27,125 - $43,548	269 Added 11.56%	2,596 $420,000
Q1 2021 Apr 19, 2021	BUY	$110.72 - $210.04 $55,027 - $104,389	497 Added 27.16%	2,327 $284,000
Q4 2020 Jan 26, 2021	BUY	$79.67 - $173.23 $145,796 - $317,010	1,830 New	1,830 $280,000

490

58M

1.1M

1.9M

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $3.19B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

Get notified when there are updates to the investment portfolio of Moseley Investment Management Inc, based on Form 13F filings with the SEC.

Stay updated on Moseley Investment Management Inc with notifications on news.